Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-011610

Head of Pharm Ops and Tech gave up 84 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 239 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2022-04-01 Option exercise +239 1,896.89 D: show line 1 in the form
Murphy Nicole Head of Pharm Ops and Tech 2022-04-01 Shares withheld for taxes −84 $210.65 $17,695 1,812.89 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2022-04-01 Option exercise · Restricted Stock Unit −239 479 D: show line 3 in the form
Loading xslF345X03/form4.xml…